胰腺腺癌不可逆电穿孔消融局部疗效评估中超声造影的无增强模式
研究纳入15例接受不可逆电穿孔消融的胰腺腺癌患者,消融后1个月行超声造影(造影剂SonoVue),以消融后3个月技术疗效为参考。技术有效组10例中7例(70.0%)消融区完全无增强,技术无效组5例全部(100.0%)周边不均匀增强;无增强模式在两组间差异有统计学意义(p=0.026),与技</br>术疗效显著相关(p=0.007),受试者工作特征曲线下面积为0.85(p=0.008,95%CI:0.65-1.05)。
要点
- 消融后1个月超声造影完全无增强模式与技术有效相关,技术有效组10例中7例(70.0%)出现。
- 技术无效组5例全部(100.0%)表现为周边不均匀增强,无增强模式在两组间差异有统计学意义(p=0.026)。
- 无增强模式诊断技术有效的曲线下面积为0.85(p=0.008,95%CI:0.65-1.05)。
核心结论
- 超声造影的无增强模式有助于评估胰腺腺癌不可逆电穿孔消融后的局部疗效。
研究设计与样本
- 15例胰腺腺癌患者接受不可逆电穿孔消融,消融后1个月行超声造影(造影剂SonoVue),以消融后3个月技术疗效(技术有效/技术无效)为参考标准,采用受试者工作特征曲线分析诊断效能。
关键影像表现/征象
- 技术有效组10例中7例消融区(70.0%)呈完全无增强。
- 技术无效组5例消融区全部(100.0%)呈周边不均匀增强。
诊断标准与关键数值
- 无增强模式在技术有效组与技术无效组间差异有统计学意义(p=0.026),且与技术疗效显著相关(p=0.007)。
- 以无增强模式评估技术有效的受试者工作特征曲线下面积为0.85(p=0.008,95%CI:0.65-1.05)。
临床应用与阅片要点
- 消融后1个月超声造影显示消融区完全无增强可能提示技术有效,周边不均匀增强可能提示技术无效。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The objective was to evaluate the diagnostic value of contrast-enhanced ultrasound in the assessment of the local efficacy after irreversible electroporation (IRE) ablation of pancreatic adenocarcinoma 1 mo after ablation. Fifteen patients with pancreatic adenocarcinoma were treated with IRE and then examined by contrast-enhanced ultrasound 1 mo after ablation. The contrast agent was SonoVue. Technical efficacy was assessed at 3 mo after IRE and classified as technical efficiency (TE) and technical inefficiency (TIE). Diagnostic performance was analyzed using a receiver operating characteristic curve. Ten patients were considered as having TE, and five, TIE. Complete non-enhancement was observed in seven ablation zones (70.0%) in the TE group, and peripheral heterogeneous enhancement, in all five ablation zones (100.0%) in the TIE group. The non-enhancement pattern differed significantly between the TE and TIE groups (p = 0.026), with significant correlation with technical efficacy (p = 0.007). The area under the receiver operating characteristic curve was 0.85 (p = 0.008, 95% confidence interval: 0.65-1.05). A non-enhancement pattern using contrast-enhanced ultrasound was useful in the assessment of local efficacy after IRE ablation of pancreatic adenocarcinoma.
引用
- Lin M, Xie X, Xu M, et al. Non-enhanced Pattern on Contrast-Enhanced Ultrasound in the Local Efficacy Assessment of Irreversible Electroporation Ablation of Pancreatic Adenocarcinoma. Ultrasound Med Biol. 2018. PMID: 30055820. doi:10.1016/j.ultrasmedbio.2018.05.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。